UGT1A1 and cancer: Inactivation of methotrexate by UGT1A enzymes has been proposed as a mechanism for resistance based on a high-throughput cell-based screen of multiple cancer drugs,34 which is consistent with resistance being related to drug glucuronidation by UGT1As.